Gabup: new buprenorphine presentation

Martindale has launched Gabup (buprenorphine) for use in opioid substitution therapy. The sublingual tablets are available in six strengths: 400 microgram, 1mg, 2mg, 4mg, 6mg and 8mg.

View Gabup drug record

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more